Guangen Xu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 1

Top Topics

Top Venues

Translational cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Kelong Tao, Chenyu Chen, Guangen Xu, Feng Tao, Meng He
Low-dose apatinib optimizes the vascular normalization and enhances the antitumor effect of PD-1 inhibitor in gastric cancer. Translational cancer research 13 (8) (2024)